CMND
Clearmind Medicine Inc.NASDAQHealthcare$1.08+8.33%ClosedMarket Cap: $147,592
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.17
P/S
0.00
EV/EBITDA
1.23
DCF Value
$10.16
FCF Yield
-4314.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-211.9%
ROA
-69.2%
ROIC
-114.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $0.00 | -Infinity% | $-3.7M | $-3.9M | $-3.32 | — |
| Q4 2025 | $0.00 | -Infinity% | $-2.0M | $-964.0K | $-6.67 | — |
| FY 2025 | $0.00 | -Infinity% | $-5.7M | $-3.9M | $-30.34 | — |
| Q3 2025 | $0.00 | -Infinity% | $-1.9M | $-1.8M | $-13.55 | — |
| Q2 2025 | $0.00 | -Infinity% | $-1.8M | $-1.1M | $-8.60 | — |
| Q1 2025 | $0.00 | -Infinity% | $-2.2M | $-1.6M | $-14.07 | — |
| Q4 2024 | $0.00 | -Infinity% | $-2.2M | $-1.2M | $-11.55 | — |
| FY 2024 | $0.00 | -Infinity% | $-8.0M | $-7.3M | $-94.38 | — |
| Q3 2024 | $0.00 | -Infinity% | $-2.0M | $-2.9M | $-32.66 | — |
| Q2 2024 | $0.00 | -Infinity% | $-1.8M | $-1.2M | $-15.26 | — |
| Q1 2024 | $0.00 | -Infinity% | $-1.9M | $-1.8M | $-48.46 | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.4M | $-5.6M | $-629.05 | — |